Your browser doesn't support javascript.
loading
Phase II and pharmacokinetic/pharmacodynamic trial of sequential topoisomerase I and II inhibition with topotecan and etoposide in advanced non-small-cell lung cancer.
Dowlati, A; Levitan, N; Gordon, N H; Hoppel, C L; Gosky, D M; Remick, S C; Ingalls, S T; Berger, S J; Berger, N A.
Affiliation
  • Dowlati A; Division of Hematology/Oncology, Case Western Reserve University and University Hospitals of Cleveland, Ohio 44106, USA. axd44@po.cwru.edu
Cancer Chemother Pharmacol ; 47(2): 141-8, 2001.
Article in En | MEDLINE | ID: mdl-11269740
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Carcinoma, Non-Small-Cell Lung / Topotecan / Enzyme Inhibitors / Etoposide / Topoisomerase I Inhibitors / Topoisomerase II Inhibitors / Lung Neoplasms Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Cancer Chemother Pharmacol Year: 2001 Document type: Article Affiliation country: Estados Unidos
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Carcinoma, Non-Small-Cell Lung / Topotecan / Enzyme Inhibitors / Etoposide / Topoisomerase I Inhibitors / Topoisomerase II Inhibitors / Lung Neoplasms Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Cancer Chemother Pharmacol Year: 2001 Document type: Article Affiliation country: Estados Unidos